Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP0113 in allogeneic HCT recipients
NCT01903928Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jun 2013
- Primary completion
- Jan 2015
- Countries
- 1
01
Overview
A Phase 2 trial of ASP0113 in cytomegalovirus infection (CMV), sponsored by Astellas Pharma. Started Jun 2013; status: completed.
02
Drugs
ASP0113
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01903928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01903928.